@ARTICLE{
author={Hanna Nasser H,Kaiser Rolf,Sullivan Richard N,Aren Osvaldo Rudy,Ahn Myung-Ju,Tiangco Beatrice,Voccia Isabelle,von Pawel Joachim,Kovcin Vladimir N,Agulnik Jason,Gaschler-Markefski Birgit,Barrueco Jose,Sikken Patricia,Schloss Charles,Kim Joo-Hang},
year={2016},
title={Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial},
journal={LUNG CANCER},
volume={102},
number={},
pages={65-73},
document_type={Article},
}